PHARMA COMPANIES COULD BENEFIT FROM TWO NEW EU RESEARCH NETWORK FUNDING INTIATIVES
May 1st, 2011
BY KEITH NUTHALL
THE EUROPEAN Union (EU) pharmaceutical sector will benefit from two new networks of research teams that will, (with a third environmental study group), benefit from Euro 700 million of European Commission funding. The first will be established by Britain and focus on systems biology and the second by France and Germany, focusing on human infections and related issues.
ENDS
THE EUROPEAN Union (EU) pharmaceutical sector will benefit from two new networks of research teams that will, (with a third environmental study group), benefit from Euro 700 million of European Commission funding. The first will be established by Britain and focus on systems biology and the second by France and Germany, focusing on human infections and related issues.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.